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Introduction
Russell and Burch’s Principles of Humane Experimen-
tal Technique constitutes the basis of current ethical 
standards in animal experimentation (Russell and 
Burch 1959). Th ey proposed the concept of the 3Rs, 
Replacement, Reduction and Refi nement, which 
continues as a framework for minimizing discomfort 
to experimental animals. Th e 3Rs has been widely 
accepted by the international scientifi c community 
and has been embedded in international legislation 
regulating the use of laboratory animals (EU 2010). 
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Summary
Russell and Burch proposed the concept of the 3Rs, Replacement, Reduction and Refi nement, 
in 1959 as a basis for ethical standards governing animal experimentation. Despite sincere at-
tempts to implement these practices, increased use of genetically modifi ed animals has created 
potential challenges to this framework. Specifi cally, genetically modifi ed animals can be dif-
fi cult to derive, and are therefore maintained continuously as a colony despite their transient 
experimental use. 
As an alternative, the use of embryo or sperm cryopreservation provides a means to effi  ciently 
archive strains and eliminate unutilized strains, avoiding the birth and use of animals to main-
tain them. It also provides substantial reductions to cost and cage occupancy. Surprisingly, 
recent work by Zeller et al. (2017) indicates that only 56% of professionals working with labora-
tory animals are aware of cryopreservation as a technique for colony management. 
Th is study shows that cryopreservation, within our institution, where the animal facility fea-
tures a housing capacity of 3,000 cages and 10,000 to 15,000 mice, has allowed us to eliminate 
effi  ciently 115 unutilized genetically modifi ed mouse strains during the past fi ve years. Th is has 
i) liberated 19% of the animal house capacity, ii) prevented the birth of 21,189 unutilized mice, 
iii) lead to a saving of 382,800 € for our institution. 
Since its initial publication, numerous eff orts 
have been made to apply the policy of 3Rs in animal 
experimentation (Festing 1995; Burch 1995). How-
ever, there are currently new challenges that must 
be addressed. Th e appearance of genetically mod-
ifi ed animals (Gordon et al. 1980), has signifi cantly 
increased the number of animal studies (Ormandy et 
al., 2009, Mazur et al. 2008; Critser and Mobraoten 
2000). As a consequence, the number of animals 
used for experimental purposes has also continued 
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to grow (Ormandy et al. 2009, Hudson-Shore 2013; 
Hudson-Shore 2014). For example, in Great Britain, 
the annual statistics for the use of experimental ani-
mals (Home Offi  ce 2016) show a clear trend in this 
regard (Table 1). Th us, in 2015, procedures for the 
creation or breeding of genetically modifi ed animals 
comprised half of the total number of procedures, 
with 91% of the animals used for the GMO produc-
tion being mice. 
Th e creation of genetically modifi ed mouse 
strains is a considerable  investment of time, money 
(it could need a minimum of 9 months and between 
25,000 and 30,000 euros (Hagn et al. 2007)) and ani-
mals. Th e number of animals used is dependent on 
many factors (Nagy 2003) although there are guides 
that off er a good framework for estimation (Institute 
for Laboratory Animal Research (U.S.), Committee 
on Guidelines for the Use of Animals in Neuroscience 
and Behavioral Research, and National Academies 
Press (U.S.) 2003). By some calculations, generating 
founders and subsequent testing may involve the use 
of at least 70 mice (Buehr et al. 2003). However, the 
subsequent number of crosses required, combined 
with the potential number of off spring obtained, 
and the animals used in the basic phenotyping of 
the line (Fuchs et al. 2011), suggest the number can 
reach at least 250 animals for each transgenic line. 
More recently, the appearance of new programmable 
genome editing tools like the CRISPR/Cas9 system 
(Jinek et al. 2012) has allowed us to introduce dif-
ferent types of mutations more effi  ciently, requiring 
less time, less money and fewer animals, as it can be 
directly used on the background of interest.
Once experimental use of a transgenic line is fi n-
ished, instead of germline cryopreservation, investi-
gators oft en maintain a minimally sized colony as a 
means to preserve their transgenic lines. Th is ‘mini-
mum level’ system not only produces ongoing waste 
of resources and animals, but does not comply with 
the recommendations for maintaining strains of 
genetically modifi ed mice (Th e Jackson Laboratory 
2009). Th is approach also increases the chances of 
fi xing other mutations in the colony due to genetic 
drift  (Taft  et al. 2006; Zeldovich 2017), the silencing 
of transgene expression (Kues et al., 2006) and may 
ultimately lead to the loss of the strain. 
Th e possibility of cryopreserving mammalian 
embryos, and subsequently thawing them to recover 
live animals, was fi rst described in mice (Whitting-
ham et al. 1972). Th is approach off ered the oppor-
tunity to archive and protect valuable strains such 
as genetically modifi ed animals (Taft  et al. 2006; 
Mobraaten 1986; Pomeroy 1991; Crabbe et al. 1993; 
Linder 2003; Wiles and Taft  2010), and has also been 
proposed as a means to manage colony size within 
animal facilities (Battey et al. 1999; Marschall and 
Hrabe de Angelis 1999; Abbott 2004; Agca 2012). 
Moreover, cryopreservation serves as a useful tool for 
’reduction’ within the 3R framework, by allowing the 
effi  cient elimination of strains of genetically modifi ed 
mice that are not being used in research (Robinson et 
al. 2004; Osborne et al. 2009; Zeller et al. 2017). 
In conclusion, cryopreservation can help to save 
the investment that creation of a new line requires, 
avoid the risks of genetic drift  and line loss, save 
resources (space and money), and most important-
ly reduce the number of animals, which is an ethical 
requirement in research.
In the current study we demonstrate how cry-
opreservation has allowed our institution to reduce 
the number of animals and save resources through 
the elimination of genetically modifi ed mouse strains 
that were not actively enrolled on research studies.
Materials and Methods
Design
A descriptive observational study was carried out 
using  data from strains cryopreserved by the Trans-
genic and Cryopreservation Laboratory of the Insti-
tuto de Neurociencias de Alicante CSIC-UMH 
between 2013 and 2017. Th e strains analyzed were 
housed in the RMG-SPF, a pathogen free animal 
facility within our institution, which has a maximum 
capacity of 3,000 cages and 10,000 to 15,000 mice, 
and a colony management program (ANIBIO®) in 
which all animals housed within the facility are reg-
istered. 
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Table 1. Scientifi c procedures on living animals. Great Britain (1995-2015). Home Offi  ce. United Kingdom Government. 
YEAR 1995 2000 2005 2010 2015
Nº GMO* PROCEDURES 312,700 699,600 1,027,200 1,621,000 2,060,000
Nº TOTAL PROCEDURES 2,709,600 2,714,700 2,896,200 3,724,700 4,140,000
PERCENTAGE GMO 11.5% 25.8% 35.5% 43.5% 49.8%
*GMO: Genetically modifi ed organism.
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modifi ed mice alive; this provided a more compre-
hensive view of what happens in other facilities. For 
the resource savings calculation, the cost of main-
taining the Transgenic and Cryopreservation Labo-
ratory was taken into account. Th is is about 90.000€ 
per year, including salaries, culture media, consum-
able materials, equipment amortization, animals, 
repairs and calibrations.
Animals
Th e mice  used for the study were born and housed 
in the RMG-SPF animal facility in the Instituto de 
Neurociencias de Alicante CSIC-UMH, under stable, 
controlled environmental conditions, according to 
standards specifi ed by national regulations. Th ere 
was a 12-hour light/dark cycle (lights on at 8:00), 
constant temperature of 22±1ºC, 55±5% relative 
humidity, and animals had free access to food and 
water. Th e procedures for embryo and sperm cry-
opreservation of the strains performed by our lab-
oratory were reviewed and approved by the UMH 
Project Evaluation Board. All genetically modifi ed 
mouse strains that were cryopreserved were part of 
research projects approved by the Spanish competent 
authority.
Data analysis
Th e data was statistically processed using the IBM® 
SPSS® Statistics Version 23.0 program. 
Due to high variability, the data obtained did 
not follow a normal distribution and showed a high 
standard deviation. To calculate the average number 
of animals born per year per line both in-use or in 
disuse, we used the interquartile range (25th to 75th 
percentile) for analysis. In order to be able to com-
pare those averages, a two-sample Student’s t-test was 
used. Th e diff erences were regarded as signifi cant 
when P < 0.05. 
Th e fl ow-chart describes the design of our study 
for determining the benefi ts of using cryopreserva-
tion based colony-size control:
 
STEP 1:
Th e number of animals produced to maintain a 
genetically modifi ed mice strain was determined. We 
obtained for each cryopreserved strain, through the 
ANIBIO® program, the number of animals born the 
year before it was cryopreserved. Th e cryopreserved 
strains were classifi ed as in-use or disuse, and the 
average number of animals born in a year to main-
tain them was then calculated and compared.
STEP 2:
We recorded when the diff erent cryopreserved strains 
were eliminated. Th e elimination of a line is refl ected 
in the reduction of animals and saving of resources 
in the years subsequent to elimination. Monitoring of 
eliminated strains was carried out until January 2018 
through the ANIBIO® program.
STEP 3:
Finally, we estimated the cumulative animal and 
resource savings generated by cryopreservation and 
elimination of genetically modifi ed mouse strains.
Th e animal reduction calculation was done using the 
value obtained per strain in the fi rst step, although 
some eliminated strains were cryopreserved the same 
year that were created or established in the RMG 
facility and so, due to the absence of previous demo-
graphic records, the average number of mice born 
per strain in disuse was used for the calculation.
For the resource savings calculation, it was nec-
essary to determine the average number of cages 
used to maintain a minimal colony of genetically 
modifi ed mice, and the annual cost of maintaining a 
mouse cage. However, in our institution, the number 
of cages used per transgenic line is not registered in 
the ANIBIO® program. We therefore relied on our 
historical breeding experience, and on data from lit-
erature searches to determine the space and money 
required to keep a minimal colony of genetically 
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STEP 3:          Estimate 
cumulative reduction 
in animals achieved by 
cryopreservation and 
elimination of strains. 
STEP 2:             




STEP 1:          
Determine the number 
of animals produced 




Number of animals born per year per 
cryopreserved line of genetically modifi ed 
mice.
Th e average number of mice born per year per cryo-
preserved line was 105.8 ± 30.7 for in-use strains and 
54.5 ± 16.1 for disuse strains (P < 0.05).
Cryopreserved strains and elimination of 
disused strains.
In the 2013-2017 period, the Transgenic and Cryo-
preservation Laboratory of the Instituto de Neuro-
ciencias de Alicante CSIC-UMH cryopreserved 215 
strains of genetically modifi ed mice. Of these, 58 cor-
responded to external services and 157 were housed 
in the RMG Facility.
By January 2018, of the 157 strains housed in 
the RMG facility, 115 (73.2%) had been completely 
eliminated aft er they were no longer in use, while 42 
strains remained alive. Of the 115 eliminated strains, 
91 (79.1%) were eliminated in the same year they 
were cryopreserved and 24 (20.9%) were eliminated 
in subsequent years. 
Regarding the exact moment of elimination, 29 
strains were eliminated in 2013, 13 in 2014, 28 in 
2015, 21 in 2016 and 24 in 2017 (Table 2).
Cumulative reduction of animals by 
cryopreservation and elimination of disused 
strains.
In 2013, 29 cryopreserved strains were eliminated 
because they were not being used. Th ese strains pro-
duced the year before their cryopreservation 1,947 
animals, so we could estimate that keeping them 
alive in that state would have generated this number 
of animals each year. Th erefore, cryopreservation and 
subsequent elimination had prevented 1,947 animals 
being born each year.
Following the same reasoning, in 2014, 13 
unused cryopreserved strains were eliminated, there-
fore preventing 693 animals being born in 2015 and 
in subsequent years.
In 2015, 28 unused cryopreserved strains were 
eliminated, and this prevented in 2016 and aft er-
wards, 1,398 animals being born every year.
In 2016, 21 cryopreserved unused strains were 
eliminated and therefore, 1,388 animals were pre-
vented from being born in 2017, and the same 
number of animals would have been avoided in 2018.
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Table 2. Cryopreserved mice strains by the Transgenic and Cryopreservation Laboratory of the Instituto de Neurociencias 











2013 35 32 29 2013 2
1 2015




2015 43 40 26 2015 7
5 2016
2 2017
2016 37 31 11 2016 14
6 2017
2017 40 22 12 2017 10







Finally, in 2017, 24 strains that had been cryo-
preserved were eliminated, which as a result, pre-
vented the birth of 1,712 animals in 2018.
Overall, cryopreservation of strains in the period 
2013-2017 and the subsequent elimination of some 
of them will have produced a cumulative reduction 
of 21,189 animals by 2018 (Table 3).
Cumulative resource savings (space and 
money) generated by cryopreservation and 
elimination of disused mouse strains
Based on our historical breeding experience, and our 
literature searches, we determined that maintaining a 
minimal colony of genetically modifi ed mice would 
require the use of 4 to 5 cages per month (Landel 
2005). Th is value was further supported by the aver-
age number of animals born annually within disused 
strains (54.5 animals, section 3.1). Th us, including 1 
or 2 breeding cages, cages with stock animals, wean-
ing etc., the use of an average of 5 cages per month 
to maintain a disused strain is a reasonable number 
and therefore has been used for calculating resource 
savings. As for the cost of maintaining these cages, 
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YEAR 2013 2014 2015 2016 2017
2014 1,947     
2015 1,947 693    
2016 1,947 693 1,398   
2017 1,947 693 1,398 1,388  
2018 1,947 693 1,398 1,388 1,712
TOTAL/YEAR 9,735 2,772 4,194 2,776 1,712
TOTAL REDUCTION 21,189
we can use the average annual value of 480 € per cage 
(Th e Jackson Laboratory 2009).
Th erefore, keeping alive the 115 strains eliminat-
ed in the study period would have required the use 
of 575 cages and occupied 19% of the total space of 
the RMG-SPF Animal Facility. In economic terms, 
we can estimate that the use of cages to keep alive the 
115 disused strains eliminated would have involved 
a cost of 832,800 € by the end of the study period. 
Taking into account the cost of cryopreservation 
(90.000 € per year for maintaining the Transgen-
ic and Cryopreservation Laboratory), we estimate a 
total cost savings in this period of 382,800 € (Table 
4). 
Discussion
Th e results of this study show how the establishment 
of a cryopreservation laboratory eliminates a signifi -
cant number of genetically modifi ed mice strains that 
are not being used and that otherwise would have 
had to be kept alive so as not to be lost. Th is has a 
clear impact on the management of animal facilities, 
by improving the use of resources, especially saving 














YEAR 2013 2014 2015 2016 2017
2014 69,600
2015 69,600 31,200
2016 69,600 31,200 67,200
2017 69,600 31,200 67,200 50,400
2018 69,600 31,200 67,200 50,400 57,600
TOTAL/YEAR 348,000 124,800 201,600 100,800 57,600
CYOPRESERVATION COST - 90,000 - 90,000 - 90,000 - 90,000 - 90,000
TOTAL COSTS SAVINGS 382,800 €
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space and money. Th e approach undertaken by our 
laboratory in the last 5 years resulted in savings of 
approximately 382,800 € and 19% of animal space 
which would otherwise have been wasted on main-
taining strains without any experimental interest. 
Keeping strains of mice in disuse alive not only 
wastes resources and animals, but, as our study 
shows, colonies usually remain at “minimum levels”, 
and this can be the source of some serious and irre-
versible problems. Th us, our results indicate that the 
average number of animals born per year in the dis-
used strains is approximately half that in the strains 
used in research 
Having fewer animals may promote genetic bot-
tlenecks in which the chances of fi xing mutations 
that arise randomly by genetic drift  increase, but 
also increases the chances of strain loss due to repro-
ductive failures or errors in animal management. In 
the 2013-2017 period this was the situation for 17 
strains in our facility. One of them lost the phenotype 
because of a promoter methylation and 16 strains 
were close to disappearing due to breeding cessa-
tion and had to be rescued from extinction by in vivo 
sampling of epididymal sperm and IVF (Del Val and 
Robledano 2013). Any of these problems can irrep-
arably lead to a loss on the initial investment asso-
ciated with establishing a strain (up to 250 animals 
per strain), and therefore the archiving through cry-
opreservation prevents that investment from being 
lost and having to be repeated. 
In addition, cryopreservation has a more impor-
tant benefi t for animal welfare by facilitating humane 
elimination of disused strains. In our institution 115 
of the 157 cryopreserved strains in the 2013-2017 
period were eliminated.  Th is resulted in a cumulative 
reduction of 21,189 animals by the year 2018, which 
otherwise would have been born if these strains had 
been kept alive. 
 In short, if we put these results in the context 
of our medium sized animal facility, which features 
a maximum capacity of 3,000 cages and housing for 
10,000 to 15,000 mice, we can see that the fi gures of 
animal reduction and resource saving are considera-
ble. Th is gives an idea of the potential that cryopres-
ervation would have if applied in a systematic way in 
all research centres to reduce the number of experi-
mental animals being used, and especially to curb the 
relentless rise in the number of animals used in the 
creation and breeding of genetically modifi ed strains.
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